PSMA, EP192, RMab
Ref BSB 6349
PSMA, EP192, RMab (BSB 6349) is a device classified as IVD General (EU), Class I (US) made by Bio Sb, Inc., registered in EUDAMED on 6 Dec 2025 (Basic UDI-DI B-B502BSB63490) and listed in FDA GUDID since 16 Mar 2020 (UDI-DI B502BSB63490), active as of 22 Oct 2026.
Active
CE IVDD
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-B502BSB63490 B502BSB63490 | Date6 Dec 2025 | StatusActive |
| United States | GUDID listing GUDID | NumberB502BSB63490 | Date16 Mar 2020 | StatusListed |
Official records
- EUDAMED public site B-B502BSB63490
Across registries
- EUDAMED Basic UDI-DI B-B502BSB63490 registered 6 Dec 2025 Active
- FDA GUDID UDI-DI B502BSB63490 listed 16 Mar 2020 Listed
Timeline
- Listed FDA GUDID B502BSB63490
- Registered EUDAMED B-B502BSB63490
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- PSMA, EP192, RMab EUDAMEDPSMA RMab GUDID
- Generic name
- Prostate-specific membrane antigen (PSMA) IVD, antibody
- Model / Ref / Catalog
- BSB 6349, Concentrate, 0.5 ml
- Primary DI / UDI-DI
- B502BSB63490
- Basic UDI-DI
- B-B502BSB63490
- FDA product code
- NJT
- EMDN code
- W01030709 Primary antisera for immunohistology
- GMDN term
- Prostate-specific membrane antigen (PSMA) IVD, antibody
- Device class
- Class IVD General EUDAMEDClass I GUDID
- Regulation number
- 864.1860
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Sweden
- GUDID distribution status
- In Commercial Distribution
- MRI safety
- MR Safe
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Model / reference | BSB 6349 | Concentrate, 0.5 ml |
| Device class | Class IVD General | Class I |
Manufacturer details
- EUDAMED SRN
- US-MF-000036462
- Authorised representative
- QAdvis EAR AB SE-AR-000001599